Among other anti-atherogenic effects such as reduction of cardiac and vascular inflammation, ANGPTL4 reduces the phenotypic transition of SMCs into macrophage-like cells in the ApoE−/− mouse model of atherosclerosis (29). This evidence concerns the gene APOE and atherosclerosis.